Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-08

Clinical Trial Update: Safety and Efficacy Study of Tarragon on Insulin Action in Humans [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial examined the safety and impact on insulin action of Tarragon in adults with obesity; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tarragon (Artemisia dracunculus)

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Obesity | Phase 1, Phase 2 | Status: COMPLETED